Arch Biopartners Inc. Logo

Arch Biopartners Inc. (ACHFF)

OTC

Currency in USD
0.7260
-0.06 (-7.40%)

Closed

Aug 26, 2026

Day's Range

0.7260
0.7539

52 wk Range

0.2880
1.24

Overview - ACHFF - Arch Biopartners Inc.

Key Statistics

Valuation

Enterprise Value

42.13M

P/E (Trailing)

‪-30.25‬

P/E (Forward)

‪-10.51‬

PEG Ratio

‪1.36‬

Price / Sales (TTM)

‪316.16‬

Price / Book

‪-13.33‬

EV / EBITDA

‪-33.93‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪-1,418.63%‬

Return on Assets

‪-276.77%‬

Return on Equity

‪40.00%‬

Ownership

Shares Outstanding

67.72M

Float

53.52M

Held by Insiders

‪18.29%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪1.72‬

50-Day Avg

‪0.6197‬

200-Day Avg

‪0.6064‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Shariah Compliant

Report Date: Feb 18, 2025

Screened by Zoya using the AAOIFI methodology.

Peers - ACHFF - Arch Biopartners Inc.

Peer Comparison

Compared with companies in Biotechnology listed on OTC.

Profile Summary - ACHFF - Arch Biopartners Inc.

About

Arch Biopartners Inc. is a biotechnology company that focuses on developing innovative medical treatments for addressing complex and unmet medical needs. The company's primary function is to conduct research and development in the field of clinical therapeutics, with a special focus on organ disease and injury. Arch…

SectorHealthcare
IndustryBiotechnology
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.